Please use this identifier to cite or link to this item:
|Title:||Are infection specialists recommending short antibiotic treatment durations? An ESCMID international cross-sectional survey||Authors:||Macheda, Gabriel
Dyar, Oliver J.
|Issue Date:||2018||Source:||JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73(4), p. 1084-1090||Abstract:||Objectives: To evaluate the current practice and the willingness to shorten the duration of antibiotic therapy among infection specialists. Methods: Infection specialists giving at least weekly advice on antibiotic prescriptions were invited to participate in an online cross-sectional survey between September and December 2016. The questionnaire included 15 clinical vignettes corresponding to common clinical cases with favourable outcomes; part A asked about the antibiotic treatment duration they would usually advise to prescribers and part B asked about the shortest duration they were willing to recommend. Results: We included 866 participants, mostly clinical microbiologists (22.8%, 197/863) or infectious diseases specialists (58.7%, 507/863), members of an antibiotic stewardship teamin 73% (624/854) of the cases, coming from 58 countries on all continents. Thirty-six percent of participants (271/749) already advised short durations of antibiotic therapy (compared with the literature) to prescribers for more than half of the vignettes and 47% (312/662) chose shorter durations in part B compared with part A for more than half of the vignettes. Twenty-two percent (192/861) of the participants declared that their regional/national guidelines expressed durations of antibiotic therapy for a specific clinical situation as a fixed duration as opposed to a range and in the multivariable analysis this was associated with respondents advising short durations for more than half of the vignettes (adjusted OR 1.5, P = 0.02). Conclusions: The majority of infection specialists currently do not advise the shortest possible duration of antibiotic therapy to prescribers. Promoting short durations among these experts is urgently needed.||Notes:||Pulcini, C (reprint author), Hop Brabois, Ctr Hosp Univ Nancy, Serv Malad Infect & Trop, Allee Morvan, F-54511 Vandoeuvre Les Nancy, France, firstname.lastname@example.org||Document URI:||http://hdl.handle.net/1942/26551||ISSN:||0305-7453||e-ISSN:||1460-2091||DOI:||10.1093/jac/dkx528||ISI #:||000429019600034||Rights:||VC The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: email@example.com. 1084||Category:||A1||Type:||Journal Contribution||Validations:||ecoom 2019|
|Appears in Collections:||Research publications|
Show full item record
Files in This Item:
|Published version||126.81 kB||Adobe PDF||View/Open Request a copy|
checked on Sep 3, 2020
WEB OF SCIENCETM
checked on May 22, 2022
checked on May 20, 2022
checked on May 20, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.